Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease

Published:2023-11-01 Issue:9 Volume:39 Page:600-610
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Evans David¹,Kenyon Kenneth²,Ousler George³,Watson Michael³,Vollmer Patrick⁴,McLaurin Eugene B.¹,Torkildsen Gail⁵,Winters Jason⁶,Dodd John⁶,Jordan Robert⁶,Wills Stephen T.⁶,Spana Carl⁶

Affiliation:

1. Total Eye Care, Memphis, Tennessee, USA.

2. Tufts University School of Medicine and New England Eye Center, Boston, Massachusetts, USA.

3. Ora, Inc., Andover, Massachusetts, USA.

4. Vita Eye Clinic, Shelby, North Carolina, USA.

5. Andover Eye Associates, Andover, Massachusetts, USA.

6. Palatin Technologies, Inc., Cranbury, New Jersey, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2023.0056

Reference22 articles.

1. The Melanocortin System in Control of Inflammation

2. 60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides

3. Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases

4. Melanocortin Regulation of Inflammation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quintessence of currently approved and upcoming treatments for dry eye disease;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-31

2. Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies;Clinical Ophthalmology;2024-08

3. Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis;Current Opinion in Allergy & Clinical Immunology;2024-07-22

4. Immunopeptides: immunomodulatory strategies and prospects for ocular immunity applications;Frontiers in Immunology;2024-07-15

5. Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death;Biomolecules;2024-01-31